CVS Health CVS
CVS Health is an integrated health company that operates retail pharmacies, pharmacy services, and a large health insurer business (Aetna), seeking to control the cost and quality of healthcare. CVS shows an attractive valuation (forward P/E 10.45, PEG 0.21) and strong earnings growth (188.8%), but its financial health is weak (ND/EBITDA 3.74, operating margin 3.86%) and it faces ongoing regulatory and legal risks.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
CVS Health is an integrated health company that operates retail pharmacies, pharmacy services, and a large health insurer business (Aetna), seeking to control the cost and quality of healthcare. CVS shows an attractive valuation (forward P/E 10.45, PEG 0.21) and strong earnings growth (188.8%), but its financial health is weak (ND/EBITDA 3.74, operating margin 3.86%) and it faces ongoing regulatory and legal risks.
Score by category
| Category | Score |
|---|---|
| Financial health | 3.2 |
| Quality / Moat | 4.1 |
| Valuation | 7.2 |
| Growth | 8.1 |
| Dividend | 6.7 |
| Momentum | 6.7 |
| Risk & Context | 7.4 |
OVERALL SCORE: 6.0/10
Context and risks
CVS operates in the US healthcare sector, subject to active regulatory scrutiny on drug pricing and health data privacy, as evidenced by the $20.5 million settlement for web tracking. Additionally, its retail pharmacy business exposes it to ongoing legal and compliance risks.
News considered in the analysis
- CVS Health (CVS) Settles Website Tracking Privacy Case For $20.5 Million — Acuerdo de 20,5 millones por privacidad; es un costo material pero manejable para una empresa de este tamaño, y refleja un riesgo regulatorio continuo en el manejo de datos de salud.
- CVS Health (CVS) Reclaims Its 200 Day EMA, Is The Stock Still A Bargain? — Análisis técnico sin información fundamental nueva; no aporta datos sobre beneficios o valoración.
- Growing gift card scam hits Walmart, Target, and CVS — Estafa que afecta a minoristas, incluida CVS; implica posibles pérdidas y costos de mitigación, pero es un problema sectorial conocido y de impacto limitado.
- Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It? — Opiniones de analistas sin información nueva; es ruido de mercado.
- What Should CVS Stock Investors Be Watching Now? — Artículo de análisis general sin hechos concretos; no aporta información nueva.
Verdict: Hold; the valuation is attractive, but debt and regulatory risks limit upside potential in the short term.
Main risk: The main risk is the high debt (ND/EBITDA 3.74) combined with a very low operating margin (3.86%), leaving little room for error against any regulatory or cost pressure.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →